Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

   417,826      
Direct Value   $6,584,566    

Indirect Value

   $17,850,076      
Total Shares   592,616      
Total Value   $24,434,642      


Agios Pharmaceuticals Inc $5,849,079 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,183 Denali Therapeutics Inc. $446,472 Regeneron Pharmaceuticals Inc $282,832 Agios Pharmaceuticals Inc $5,849,079 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,183 Denali Therapeutics Inc. $446,472 Regeneron Pharmaceuticals Inc $282,832
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 127.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-11-01 4 AS $63.32 $383,105 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-12-01 4 AS $61.51 $369,288 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-12-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2017-12-12 4 A $0.00 $0 I/I 249,998 19,774 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 OE $0.30 $16,033 D/D 53,000 53,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 AS $71.77 $3,877,218 D/D (53,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 OE $0.30 $9,945 D/D 32,875 32,875 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 AS $80.01 $2,630,329 D/D (32,875) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,600 D/D (20) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $6 D/D 20 20 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,082,775 D/D (13,533) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $4,094 D/D 13,533 13,533 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 OE $0.30 $7,131 D/D 23,572 23,572 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 AS $80.35 $1,911,494 D/D (23,572) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-02-01 4 AS $78.50 $1,023,756 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-02-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-03-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-03-01 4 AS $80.38 $1,054,218 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-04-02 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-04-02 4 AS $75.54 $1,010,357 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-01 4 AS $82.88 $1,079,501 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 OE $0.30 $14,936 D/D 49,374 49,374 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 AS $90.11 $4,463,524 D/D (49,374) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-30 4 OE $0.30 $17,675 D/D 45,626 45,626 0 -
  154  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us